| 1 |
Purification and characterization of catalytic domains of gelatinase A with or without fibronectin insert for high-throughput inhibitor screening
Cheng DH, Shen Q, Nan FJ, Qian Z, Ye QZ
Protein Expression and Purification, 27(1), 63, 2003 |
| 2 |
Trichostatin A - histone deacetylase inhibitor with clinical therapeutic potential - is also a selective and potent inhibitor of gelatinase A expression
Ailenberg M, Silverman M
Biochemical and Biophysical Research Communications, 298(1), 110, 2002 |
| 3 |
Human membrane type-2 matrix metalloproteinase is defective in cell-associated activation of progelatinase A
Miyamori H, Takino T, Seiki M, Sato H
Biochemical and Biophysical Research Communications, 267(3), 796, 2000 |
| 4 |
Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: Inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells
Jiang C, Agarwal R, Lu JX
Biochemical and Biophysical Research Communications, 276(1), 371, 2000 |
| 5 |
Expression and purification of soluble and inactive mutant forms of membrane type 1 matrix metalloproteinase
Valtanen H, Lehti K, Lohi J, Keski-Oja J
Protein Expression and Purification, 19(1), 66, 2000 |
| 6 |
Structure of human pro-matrix metalloproteinase-2: Activation mechanism revealed
Morgunova E, Tuuttila A, Bergmann U, Isupov M, Lindqvist Y, Schneider G, Tryggvason K
Science, 284(5420), 1667, 1999 |
| 7 |
Complementarity of Combinatorial Chemistry and Structure-Based Ligand Design - Application to the Discovery of Novel Inhibitors of Matrix Metalloproteinases
Rockwell A, Melden M, Copeland RA, Hardman K, Decicco CP, Degrado WF
Journal of the American Chemical Society, 118(42), 10337, 1996 |
